Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent.

[1]  R. Siegel,et al.  Augmentation of Coronary Blood Flow by Intra‐aortic Balloon Pumping in Patients After Coronary Angioplast , 1993, Circulation.

[2]  J. Ducas,et al.  Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator. , 1992, Journal of the American College of Cardiology.

[3]  J. Patton,et al.  Coronary thrombolysis. Comparative effects of intracoronary administration of recombinant tissue plasminogen activator and urokinase. , 1992, Chest.

[4]  E. Topol,et al.  Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock. , 1991, Journal of the American College of Cardiology.

[5]  J. Patton,et al.  Coronary thrombolysis with recombinant tissue plasminogen activator. Intracoronary vs intravenous administration. , 1991, Chest.

[6]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[7]  Dwight E. Peake,et al.  Thrombolysis in myocardial infarction (TIMI) trial: Phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase , 1988 .

[8]  R Roberts,et al.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. , 1987, Circulation.

[9]  Harold T. Dodge,et al.  Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase* , 1987 .

[10]  Y. Ohtsuki,et al.  ISOLATION OF HTLV-I FROM CEREBROSPINAL FLUID OF A PATIENT WITH MYELOPATHY , 1986, The Lancet.

[11]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.

[12]  S. Port,et al.  Effects of intraaortic balloon counterpulsation on myocardial blood flow in patients with severe coronary artery disease. , 1984, Journal of the American College of Cardiology.

[13]  P. Bardfeld,et al.  Work in progress: detection of deep venous thrombosis with 99mTc-sulfur colloid. , 1983, Radiology.

[14]  Ying Sun,et al.  Effect of intraaortic balloon counterpulsation on regional myocardial blood flow and oxygen consumption in the presence of coronary artery stenosis: observations in an awake animal model. , 1982, The American journal of cardiology.

[15]  A. Freeman,et al.  Uptake of 99Tcm colloid by intravascular clot. , 1976, The British journal of radiology.

[16]  E. Veys,et al.  HL-A AND INFECTIVE SACROILEITIS , 1974 .